COMPANY PROFILE

Luda Partners

Explore full profile

The first pharmaceutical technology platform for pharmacists

Madrid, SpainFounded 2017Biotech & Life Sciences

Valuation <$5M Last recorded · 2026

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Luda Partners

LUDA Partners operates a digital network designed to assist pharmacies in addressing supply chain problems and advancing their digital capabilities. The company serves pharmacies by facilitating communication and collaboration to locate drugs that are in short supply. LUDA Partners operates in the healthcare and pharmaceutical market, focusing on the digital transformation of pharmacy operations. The business model is based on providing a platform that connects pharmacies, enabling them to share information and resources efficiently. Revenue is generated through subscription fees or service charges paid by the participating pharmacies. LUDA Partners aims to position pharmacies at the center of a digital ecosystem, enhancing their operational efficiency and service delivery.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Madrid, Spain
Employees: 62
Open positions: 4
Dealroom signal: 85.9/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, Digital Pharma, DT and LS, science-based
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Mar 2026	$750K	$3M	Dozen Investments	↗
EARLY VC✓Equity / VC	Feb 2024	$13M	$53M	Moira Capital Partners	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Luda Partners website traffic

Latest recorded traffic for Luda Partners is 3.4K monthly website visits, up 21.4% over the last three months. Luda Partners's team grew 17% over the past year.

Latest monthly visits3.4K 3-month web change+21.4% 1-year team growth+17%

Monthly website visitsApr 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Prácticas RRHH - People and CultureMadrid, Community of Madrid, Spain · Marketing & Communication · Aug 4, 2026 Prácticas Marketing y diseño - LUDA PartnersMadrid, Community of Madrid, Spain · Marketing & Communication · Aug 4, 2026 Prácticas: Community Manager Creativo & Social MediaMadrid, Community of Madrid, Spain · Marketing & Communication · Jul 12, 2026 ¡Déjanos tu curriculum!Madrid, Community of Madrid, Spain · Full-Stack Development · Jul 10, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AIAirBiometricsHelps to regain sovereignty over well-being	Castellón de la Plana, Spain	Operational	8	$220K	$880K
ANAntegenesGenetic tests for personalized cancer risk prevention	Tartu, Estonia	Operational
VEVETBIOLIXDevelops innovative products for the treatment and prevention of chronic diseases affecting chi	Loos, France	Operational
R(Research Grid (R.grid)AI-powered automation engine for admin-free clinical trials	Norwich, United Kingdom	Operational
VIVitroScanDedicated to delivering predictive diagnostic testing to support better informed treatment decisions for cancer patients	Leiden, Netherlands	Operational
BIBionamicOffers applications for handling and analyzing antibody discovery related data	Lund Municipality, Sweden	Operational
ZHZio HealthPocket-sized biosensor technology for point-of-care molecular testing	London, United Kingdom	Operational
KIKinomicaPhosphoproteomic diagnostic platform for precision oncology therapy selection	Macclesfield, United Kingdom	Operational